SANOFI NEWS

Own midcaps? Do a check & balance exercise to avoid decision of haste: 7 midcaps from different sectors with an upside potential of upto 49%

Every now and then the market goes through phases, where it prefers a certain set of stocks, not based on sector but based on the overall market cap. So, sometimes it is large caps, at other mid-caps. Now this partially happens, due to the flows which are coming to markets. For example, if more flows are coming to mid-cap or multicap schemes there is bound to be out performance in the mid-cap space. Now what it does is that it tends to create a sudden surge in mid-cap. Similarly when there is an outflow like the kind of one which we saw in March this year, midcap stocks tend to decline sharply. Essentially, it is the flows which impact the broader matrix of how midcaps behave. So there are phases not owning a midcap stocks appeared to sin and then there phase, where owning them appears to be sin. But if one focuses on the underlying business and some critical parameters, there is a possibility of getting rid of these phases of anxiety which keep coming to the street and create long term wealth.

Add Sanofi India, target price Rs 9170: ICICI Securities

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 19074.08 Crore) operating in Pharmaceuticals sector.

Stocks in news: JSW Energy, IDFC First Bank, Zydus Life, Alkem Labs, Tata Elxsi

JSW Energy's board to meet on April 2 to consider a proposal for raising of funds through the issuance of eligible securities of the company by way of private offerings or on a preferential allotment basis.

Stocks in news: Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare

Equity indices declined on Tuesday. Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare among top stocks to track today.

Hold Sanofi India, target price Rs 9170: ICICI Securities

Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2022.

Will the wave of restructuring help? 7 MNC pharma stocks with upside potential of up to 14%

In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of these restructuring are being done as part of the global readjustment being made at the parent companies level. The bigger question is whether after this restructuring will the MNC pharma stocks, which have been underperforming for quite some time, be able to make a comeback on the street or not. This answer to this question would depend on multiple factors. Right from the use of the sale proceeds to whether post restructuring focus would be on a 100 percent subsidiary or not. In both positive and negative cases, these stocks probably should be on watchlist as news flow around them increases in coming quarters. We take a look at 7 MNC pharma companies.

Sanofi plans to split consumer health unit to narrow focus

Sanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a separately listed company based in France. The move could occur as soon as the fourth quarter of 2024, it said in astatement Friday.

Stocks in focus: Zaggle, Sanofi India and more

Stocks in news: LIC, Hero MotoCorp, Nykaa, Adani Wilmar, Biocon

Hero MotoCorp reported a 32% growth in net profit for the quarter ended June to Rs 825 crore. Revenue from operations grew 4.5% YoY to Rs 8,767 crore.

Stock market update: Nifty Pharma index advances 1.46%

The Nifty Pharma index closed 1.46 per cent up at 14299.05.

Stock market update: Nifty Pharma index advances 0.47% in an upbeat market

The Nifty Pharma index was trading 0.47 per cent up at 14083.45.

Stock market update: Nifty Pharma index falls 0.36% in an upbeat market

The Nifty Pharma index was trading 0.36 per cent down at 14002.6.

Stock market update: Nifty Pharma index advances 0.72%

The Nifty Pharma index closed 0.72 per cent up at 13871.6.

Stock market update: Nifty Pharma index advances 0.55% in an upbeat market

The Nifty Pharma index was trading 0.55 per cent up at 13847.3.

Stock market update: Nifty Pharma index advances 0.71%

The Nifty Pharma index closed 0.71 per cent up at 13772.0.

Stock market update: Nifty Pharma index advances 0.45%

The Nifty Pharma index closed 0.45 per cent up at 13675.45.

Stock market update: Nifty Pharma index falls 0.02% in an upbeat market

The Nifty Pharma index was trading 0.02 per cent down at 13610.9.

Stock market update: Nifty Pharma index advances 1.46%

The Nifty Pharma index closed 1.46 per cent up at 13622.75.

Stock market update: Nifty Pharma index falls 0.28% in a weak market

The Nifty Pharma index was trading 0.28 per cent down at 13129.7.

Stock market update: Nifty Pharma index advances 0.07%

The Nifty Pharma index closed 0.07 per cent up at 13247.7.

Stock market update: Nifty Pharma index falls 0.17% in an upbeat market

The Nifty Pharma index was trading 0.17 per cent down at 13216.35.

Stock market update: Nifty Pharma index falls 0.19%

The Nifty Pharma index closed 0.19 per cent down at 13238.85.

Stock market update: Nifty Pharma index falls 0.13%

The Nifty Pharma index closed 0.13 per cent down at 12976.8.